Adults aged 18–80 years with type 2 diabetes for ≥1 year, HbA1c ≥0.5% above target despite ≥2 non-insulin glucose-lowering drugs or insulin, therapy stable ≥4 months. The gene discussed is INS; the disease is type 2 diabetes mellitus.